Your browser doesn't support javascript.
loading
Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group.
Rau, Rachel E; Dai, Yunfeng; Devidas, Meenakshi; Rabin, Karen R; Zweidler-McKay, Patrick; Angiolillo, Anne; Schore, Reuven J; Burke, Michael J; Salzer, Wanda L; Heerema, Nyla A; Carroll, Andrew J; Winick, Naomi J; Hunger, Stephen P; Raetz, Elizabeth A; Loh, Mignon L; Wood, Brent L; Borowitz, Michael J.
Afiliación
  • Rau RE; Division of Pediatric Hematology/Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
  • Dai Y; Department of Biostatistics, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville, Florida, USA.
  • Devidas M; Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Rabin KR; Division of Pediatric Hematology/Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
  • Zweidler-McKay P; Immunogen, Inc., Waltham, Massachusetts, USA.
  • Angiolillo A; Division of Pediatric Oncology, Children's National Medical Center, Washington, DC and the George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
  • Schore RJ; Division of Pediatric Oncology, Children's National Medical Center, Washington, DC and the George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
  • Burke MJ; Division of Pediatric Hematology-Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Salzer WL; U.S. Army Medical Research and Materiel Command, Fort Detrick, Frederick, Maryland, USA.
  • Heerema NA; Department of Pathology, The Ohio State University Wexner School of Medicine, Columbus, Ohio, USA.
  • Carroll AJ; Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Winick NJ; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Hunger SP; Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Raetz EA; Department of Pediatrics, New York University Langone Medical Center, New York, New York, USA.
  • Loh ML; Department of Pediatrics, Benioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California School of Medicine, San Francisco, California, USA.
  • Wood BL; Department of Pathology and Laboratory Medicine, Children's Hospital of Los Angeles, University of Southern California, Los Angeles, California, USA.
  • Borowitz MJ; Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Pediatr Blood Cancer ; 68(4): e28929, 2021 04.
Article en En | MEDLINE | ID: mdl-33559396

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasia Residual / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: America do norte Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasia Residual / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: America do norte Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos